Altogether, the 4 newest IgAN drugs -- sparsentan, targeted-release budesonide, iptacopan, and atrasentan -- were prescribed to less than 5% of patients in a 2024-2025 US database. A new study ...
Review authors suggested guidelines to help in standardizing future lupus nephritis studies. Heterogeneity in lupus nephritis (LN) trial design substantially hinders interpretation of studied drugs’ ...
Retinal age gap significantly higher in participants with diabetes, cardiac disease, or stroke. (HealthDay News) — Retinal age, derived from a single fundus photograph, is a biomarker of clinical ...
Cancer patients who experience a recent financial hardship have an increased likelihood of spending more on health care at the end of life.
Older adults with RSV had higher mortality rates, greater health care utilization, and more cardiovascular complications than older adults with influenza.
Real-time continuous glucose monitoring (CGM) improves blood glucose management in adults with type 2 diabetes managed with basal insulin, according to a stud ...
Individuals with incident CVD events had lower cognitive function starting three to eight years before the event.
Lower normalized dietary protein intake linked to lower composite risk, with no difference in nutritional markers.
Men diagnosed at screening aged 50 years projected to have 16 percent chance that cancer would not have been detected within 15 years.
The U.S. Food and Drug Administration (FDA) is moving to speed drug development and review by launching real-time clinical trials. The move could soon mean more options for patients who need ...
The majority (62%) of patients with PAH who completed the narrative at 12 months described living with the disease as “manageable.” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results